The Diatrizoate Meglumine Injection, cataloged under National Stock Number 6505-01-265-0055, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bracco Diagnostics Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-265-0055 |
| Primary Part Number | NDC00270-1410-30 |
| Item Name | Diatrizoate Meglumine Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bracco Diagnostics Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 300.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 18.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00270-1410-30 PRIMARY | Bracco Diagnostics Inc. (USA) |
| Reference | Meaning |
|---|---|
| CYSTOGRAFIN DILUTE | 5/1 Secondary reference Bracco Diagnostics Inc. |
NSN 6505-01-265-0055 is a Diatrizoate Meglumine Injection, manufactured by Bracco Diagnostics Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-265-0055 has 1 manufacturer part number on file: NDC00270-1410-30 (Bracco Diagnostics Inc.).
Key specifications for NDC00270-1410-30: Primary Container Content Quantity: 300.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: STOPPER SHALL BE COMPATIBLE WITH PIERCING DEVICE OF THE STOCK LISTED INTRAVENOUS INJECTION SETS. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.